REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Uvera S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Toilet Preparation Manufacturing | Other Chemical Product and Preparation Manufacturing | All Other Chemical Product and Preparation Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Uvera S.A. Profile Updated: October 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Uvera S.A. is a company in Poland, with a head office in Lodz. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was incorporated on December 12, 2018. 11 - 50 (2024) employees currently work for Uvera S.A.. There was a total negative growth of 22.95% in Uvera S.A.’s total assets over the same period.

Headquarters
Ul. Dr. Jana Muszynskiego 2/3.18
Lodz; Lodzkie; Postal Code: 90-151

Contact Details: Purchase the Uvera S.A. report to view the information.

Website: http://www.uvera.eu

Basic Information
Total Employees:
Purchase the Uvera S.A. report to view the information.
Outstanding Shares:
Purchase the Uvera S.A. report to view the information.
Registered Capital:
Purchase the Uvera S.A. report to view the information.
Financial Auditors:
Purchase the Uvera S.A. report to view the information.
Incorporation Date:
December 12, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Uvera S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-11.99%▼
Operating profit (EBIT)
23.25%▲
EBITDA
21.16%▲
Net Profit (Loss) for the Period
-2.47%▼
Total assets
-22.95%▼
Total equity
-24.22%▼
Return on Equity (ROE)
-8.33%▼
Debt to Equity Ratio
13.87%▲
Quick Ratio
-12.66%▼
Cash Ratio
-14.22%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Biovirtus Research Site Sp. z o.o.
 
Pharmacy Research Institute Sp. z o.o.
Proper Medical Writing Sp. z o.o.
 
Alcid Sp. z o.o.
Iclab Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo